3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
57
Phase 1/2
14
Phase 3
8
Phase 1
7
Phase NA
5
Phase EARLY_PHASE1
3
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
CNS
1
Conditions
Colorectal Neoplasms
13
Carcinoma, Hepatocellular
6
Colonic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Uterine Cervical Neoplasms
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Fallopian Tube Neoplasms
2
Astrocytoma
2
Vipoma
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Somatostatinoma
1
Small Cell Lung Carcinoma
1
Recurrence
1
Progression Free Survival
1
Oropharyngeal Neoplasms
1
Oesophagogastric Cancer
1
Neuroendocrine Tumors
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Mesothelioma
1
Lymphoid Interstitial Pneumonia
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Insulinoma
1
Inflammatory Breast Neoplasms
1
Hypopharyngeal Neoplasms
1
Interventions
Lomustine
2
Gefitinib
2
Carboplatin
2
trofosfamide
1
tozuleristide
1
entrectinib
1
Vincristine
1
Thiotepa
1
Temozolomide
1
Sunitinib
1
Radiotherapy
1
Methylprednisolone
1
Maintenance Chemotherapy
1
Magnetic Resonance Spectroscopy
1
Induction Chemotherapy
1
Etoposide
1
Erlotinib Hydrochloride
1
Diploidy
1
Dexamethasone
1
Cyclophosphamide
1
Cisplatin
1
Cholecalciferol
1
Bevacizumab
1
Adrenal Cortex Hormones
1
AZD3759
1
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Brain Neoplasms
×
Bevacizumab
×
Clear all
NCT05807893
2024-11-13
SUPER BRAIN
Sun Yat-sen University
Phase 2/3
Completed
40 enrolled